PureTech Net Tangible Assets vs Capital Stock Analysis
PRTC Stock | USD 21.80 1.45 7.13% |
PureTech Health financial indicator trend analysis is much more than just breaking down PureTech Health PLC prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PureTech Health PLC is a good investment. Please check the relationship between PureTech Health Net Tangible Assets and its Capital Stock accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Net Tangible Assets vs Capital Stock
Net Tangible Assets vs Capital Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PureTech Health PLC Net Tangible Assets account and Capital Stock. At this time, the significance of the direction appears to have weak relationship.
The correlation between PureTech Health's Net Tangible Assets and Capital Stock is 0.36. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Capital Stock in the same time period over historical financial statements of PureTech Health PLC, assuming nothing else is changed. The correlation between historical values of PureTech Health's Net Tangible Assets and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of PureTech Health PLC are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Net Tangible Assets i.e., PureTech Health's Net Tangible Assets and Capital Stock go up and down completely randomly.
Correlation Coefficient | 0.36 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Capital Stock
The total amount of a company's capital funded by shareholders through the issue and subscription of shares.Most indicators from PureTech Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PureTech Health PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. At present, PureTech Health's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 8.14, whereas Issuance Of Capital Stock is forecasted to decline to about 1.1 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 4.7M | 4.0M | 13.5M | 14.2M | Depreciation And Amortization | 7.2M | 8.9M | 4.9M | 7.0M |
PureTech Health fundamental ratios Correlations
Click cells to compare fundamentals
PureTech Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PureTech Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 941.2M | 990.0M | 946.0M | 702.6M | 694.0M | 544.9M | |
Short Long Term Debt Total | 39.3M | 76.6M | 52.0M | 46.9M | 25.3M | 26.1M | |
Other Current Liab | 101.5M | 141.1M | 205.3M | 57.9M | 29.6M | 28.2M | |
Total Current Liabilities | 139.2M | 180.9M | 226.1M | 96.9M | 51.4M | 48.8M | |
Total Stockholder Equity | 668.0M | 669.7M | 593.5M | 542.2M | 464.1M | 367.8M | |
Property Plant And Equipment Net | 43.8M | 42.9M | 43.9M | 37.2M | 19.4M | 19.9M | |
Current Deferred Revenue | 22.2M | 22.6M | 31.3M | 2.2M | (29.5M) | (28.0M) | |
Net Debt | (93.1M) | (327.3M) | (413.7M) | (103.0M) | (165.7M) | (174.0M) | |
Retained Earnings | 254.4M | 260.4M | 199.9M | 149.5M | 83.8M | 88.0M | |
Accounts Payable | 11.1M | 8.9M | 11.3M | 26.5M | 14.6M | 10.4M | |
Cash | 132.4M | 403.9M | 465.7M | 149.9M | 191.1M | 180.3M | |
Non Current Assets Total | 772.3M | 575.6M | 444.2M | 316.5M | 346.8M | 257.8M | |
Non Currrent Assets Other | 32.3M | 531.9M | 399.3M | 278.4M | 879K | 835.1K | |
Cash And Short Term Investments | 162.4M | 403.9M | 465.7M | 350.1M | 327.1M | 273.9M | |
Common Stock Total Equity | 4.7M | 5.4M | 5.4M | 5.4M | 4.9M | 4.6M | |
Common Stock Shares Outstanding | 29.2M | 292.9M | 286.6M | 284.8M | 276.3M | 290.1M | |
Short Term Investments | 30.1M | (1.7M) | (1.3M) | 200.2M | 136.1M | 93.3M | |
Liabilities And Stockholders Equity | 941.2M | 990.0M | 946.0M | 702.6M | 694.0M | 544.9M | |
Non Current Liabilities Total | 151.6M | 155.5M | 135.7M | 58.2M | 184.4M | 193.6M | |
Other Current Assets | 1.9M | 7.5M | 32.5M | 23.8M | 17.7M | 11.1M | |
Other Stockholder Equity | 408.2M | 265.4M | 249.7M | 263.1M | 245.6M | 279.0M | |
Total Liab | 290.8M | 336.5M | 361.9M | 155.1M | 235.7M | 223.8M | |
Property Plant And Equipment Gross | 43.8M | 42.9M | 58.3M | 57.3M | 32.3M | 24.3M | |
Total Current Assets | 168.8M | 414.3M | 501.8M | 386.2M | 347.2M | 287.1M | |
Accumulated Other Comprehensive Income | (18.3M) | (23.6M) | (39.6M) | (14.4M) | 129.1M | 135.6M | |
Short Term Debt | 4.4M | 29.7M | 9.4M | 12.5M | 7.1M | 9.8M | |
Intangible Assets | 625K | 899K | 987K | 831K | 906K | 860.7K | |
Common Stock | 5.4M | 5.4M | 5.4M | 5.5M | 5.5M | 5.2M | |
Other Liab | 116.7M | 108.6M | 92.4M | 23.8M | 27.3M | 26.0M | |
Net Tangible Assets | 667.4M | 668.8M | 592.5M | 541.4M | 622.6M | 490.8M | |
Other Assets | 819K | 2.3M | 1K | 2.1M | 1.0 | 0.95 | |
Net Receivables | 2.3M | 2.9M | 3.6M | 12.3M | 2.4M | 3.7M | |
Short Long Term Debt | 1.5M | 26.5M | 4.8M | 7.5M | 3.7M | 7.0M | |
Non Current Liabilities Other | 1.8M | 138K | (1K) | 1K | 110.2M | 115.7M | |
Property Plant Equipment | 8.3M | 43.8M | 42.9M | 43.9M | 50.5M | 28.0M | |
Net Invested Capital | 669.5M | 711.0M | 612.5M | 560.0M | 467.8M | 554.7M | |
Net Working Capital | 29.6M | 233.4M | 275.7M | 289.3M | 295.8M | 163.8M | |
Capital Lease Obligations | 37.8M | 35.3M | 33.0M | 29.1M | 21.6M | 28.8M | |
Capital Stock | 5.4M | 5.4M | 5.4M | 5.5M | 5.5M | 6.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PureTech Health PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PureTech Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puretech Health Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puretech Health Plc Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.615 | Earnings Share (3.00) | Revenue Per Share 0.02 | Quarterly Revenue Growth (0.91) | Return On Assets (0.13) |
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.